vs
奥尼兰姆制药（ALNY）与Fabrinet（FN）财务数据对比。点击上方公司名可切换其他公司
Fabrinet的季度营收约是奥尼兰姆制药的1.0倍（$1.1B vs $1.1B），奥尼兰姆制药净利率更高（17.0% vs 9.9%，领先7.1%），奥尼兰姆制药同比增速更快（84.9% vs 35.9%），奥尼兰姆制药自由现金流更多（$140.3M vs $-5.3M），过去两年奥尼兰姆制药的营收复合增速更高（49.0% vs 24.4%）
奥尼兰姆制药是美国生物制药企业，2002年成立，总部位于马萨诸塞州剑桥市，专注于研发及商业化针对基因明确疾病的RNA干扰（RNAi）疗法，2016年入选福布斯「100家最具创新力成长企业」榜单。
Fabrinet（股票代码FN）为标普中型股400指数成分股。该指数由标普道琼斯指数公司维护，覆盖400家以美企为主的中等市值企业，若成分企业存在多类流通股，指数的成分股总量有时会超过400只。
ALNY vs FN — 直观对比
营收规模更大
FN
是对方的1.0倍
$1.1B
营收增速更快
ALNY
高出49.0%
35.9%
净利率更高
ALNY
高出7.1%
9.9%
自由现金流更多
ALNY
多$145.6M
$-5.3M
两年增速更快
ALNY
近两年复合增速
24.4%
损益表 — Q4 FY2025 vs Q2 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $1.1B | $1.1B |
| 净利润 | $186.4M | $112.6M |
| 毛利率 | 75.6% | 12.2% |
| 营业利润率 | 12.0% | 10.1% |
| 净利率 | 17.0% | 9.9% |
| 营收同比 | 84.9% | 35.9% |
| 净利润同比 | 322.6% | 30.0% |
| 每股收益（稀释后） | $1.44 | $3.11 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ALNYFN
| Q4 25 | $1.1B | $1.1B | ||
| Q3 25 | $1.2B | $978.1M | ||
| Q2 25 | $773.7M | $909.7M | ||
| Q1 25 | $594.2M | $871.8M | ||
| Q4 24 | $593.2M | $833.6M | ||
| Q3 24 | $500.9M | $804.2M | ||
| Q2 24 | $659.8M | $753.3M | ||
| Q1 24 | $494.3M | $731.5M |
净利润ALNYFN
| Q4 25 | $186.4M | $112.6M | ||
| Q3 25 | $251.1M | $95.9M | ||
| Q2 25 | $-66.3M | $87.2M | ||
| Q1 25 | $-57.5M | $81.3M | ||
| Q4 24 | $-83.8M | $86.6M | ||
| Q3 24 | $-111.6M | $77.4M | ||
| Q2 24 | $-16.9M | $81.1M | ||
| Q1 24 | $-65.9M | $80.9M |
毛利率ALNYFN
| Q4 25 | 75.6% | 12.2% | ||
| Q3 25 | 84.2% | 11.9% | ||
| Q2 25 | 81.6% | 12.2% | ||
| Q1 25 | 88.2% | 11.7% | ||
| Q4 24 | 82.7% | 12.1% | ||
| Q3 24 | 83.6% | 12.3% | ||
| Q2 24 | 89.8% | 12.3% | ||
| Q1 24 | 89.0% | 12.4% |
营业利润率ALNYFN
| Q4 25 | 12.0% | 10.1% | ||
| Q3 25 | 29.5% | 9.6% | ||
| Q2 25 | -2.1% | 9.8% | ||
| Q1 25 | 3.0% | 9.0% | ||
| Q4 24 | -17.7% | 9.5% | ||
| Q3 24 | -15.4% | 9.6% | ||
| Q2 24 | 7.4% | 9.7% | ||
| Q1 24 | -8.8% | 9.7% |
净利率ALNYFN
| Q4 25 | 17.0% | 9.9% | ||
| Q3 25 | 20.1% | 9.8% | ||
| Q2 25 | -8.6% | 9.6% | ||
| Q1 25 | -9.7% | 9.3% | ||
| Q4 24 | -14.1% | 10.4% | ||
| Q3 24 | -22.3% | 9.6% | ||
| Q2 24 | -2.6% | 10.8% | ||
| Q1 24 | -13.3% | 11.1% |
每股收益（稀释后）ALNYFN
| Q4 25 | $1.44 | $3.11 | ||
| Q3 25 | $1.84 | $2.66 | ||
| Q2 25 | $-0.51 | $2.41 | ||
| Q1 25 | $-0.44 | $2.25 | ||
| Q4 24 | $-0.66 | $2.38 | ||
| Q3 24 | $-0.87 | $2.13 | ||
| Q2 24 | $-0.13 | $2.22 | ||
| Q1 24 | $-0.52 | $2.21 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $1.7B | $960.8M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $789.2M | $2.2B |
| 总资产 | $5.0B | $3.3B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资ALNYFN
| Q4 25 | $1.7B | $960.8M | ||
| Q3 25 | $1.5B | $968.8M | ||
| Q2 25 | $1.1B | $934.2M | ||
| Q1 25 | $1.0B | $950.7M | ||
| Q4 24 | $966.4M | $934.6M | ||
| Q3 24 | $1.1B | $908.9M | ||
| Q2 24 | $968.5M | $858.6M | ||
| Q1 24 | $681.9M | $794.0M |
股东权益ALNYFN
| Q4 25 | $789.2M | $2.2B | ||
| Q3 25 | $233.9M | $2.1B | ||
| Q2 25 | $250.6M | $2.0B | ||
| Q1 25 | $115.4M | $1.9B | ||
| Q4 24 | $67.1M | $1.8B | ||
| Q3 24 | $32.4M | $1.8B | ||
| Q2 24 | $-3.1M | $1.7B | ||
| Q1 24 | $-219.3M | $1.7B |
总资产ALNYFN
| Q4 25 | $5.0B | $3.3B | ||
| Q3 25 | $4.9B | $3.0B | ||
| Q2 25 | $4.6B | $2.8B | ||
| Q1 25 | $4.2B | $2.6B | ||
| Q4 24 | $4.2B | $2.5B | ||
| Q3 24 | $4.2B | $2.4B | ||
| Q2 24 | $4.0B | $2.3B | ||
| Q1 24 | $3.8B | $2.2B |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $163.6M | $46.3M |
| 自由现金流经营现金流 - 资本支出 | $140.3M | $-5.3M |
| 自由现金流率自由现金流/营收 | 12.8% | -0.5% |
| 资本支出强度资本支出/营收 | 2.1% | 4.6% |
| 现金转化率经营现金流/净利润 | 0.88× | 0.41× |
| 过去12个月自由现金流最近4个季度 | $465.4M | $102.3M |
8季度趋势，按日历期对齐
经营现金流ALNYFN
| Q4 25 | $163.6M | $46.3M | ||
| Q3 25 | $325.1M | $102.6M | ||
| Q2 25 | $153.7M | $55.1M | ||
| Q1 25 | $-118.3M | $74.2M | ||
| Q4 24 | $-94.7M | $115.9M | ||
| Q3 24 | $43.7M | $83.2M | ||
| Q2 24 | $124.2M | $83.1M | ||
| Q1 24 | $-81.5M | $100.9M |
自由现金流ALNYFN
| Q4 25 | $140.3M | $-5.3M | ||
| Q3 25 | $313.0M | $57.3M | ||
| Q2 25 | $139.4M | $4.7M | ||
| Q1 25 | $-127.3M | $45.7M | ||
| Q4 24 | $-103.8M | $94.0M | ||
| Q3 24 | $39.5M | $62.9M | ||
| Q2 24 | $116.1M | $70.4M | ||
| Q1 24 | $-94.5M | $87.3M |
自由现金流率ALNYFN
| Q4 25 | 12.8% | -0.5% | ||
| Q3 25 | 25.1% | 5.9% | ||
| Q2 25 | 18.0% | 0.5% | ||
| Q1 25 | -21.4% | 5.2% | ||
| Q4 24 | -17.5% | 11.3% | ||
| Q3 24 | 7.9% | 7.8% | ||
| Q2 24 | 17.6% | 9.3% | ||
| Q1 24 | -19.1% | 11.9% |
资本支出强度ALNYFN
| Q4 25 | 2.1% | 4.6% | ||
| Q3 25 | 1.0% | 4.6% | ||
| Q2 25 | 1.8% | 5.5% | ||
| Q1 25 | 1.5% | 3.3% | ||
| Q4 24 | 1.5% | 2.6% | ||
| Q3 24 | 0.8% | 2.5% | ||
| Q2 24 | 1.2% | 1.7% | ||
| Q1 24 | 2.6% | 1.9% |
现金转化率ALNYFN
| Q4 25 | 0.88× | 0.41× | ||
| Q3 25 | 1.29× | 1.07× | ||
| Q2 25 | — | 0.63× | ||
| Q1 25 | — | 0.91× | ||
| Q4 24 | — | 1.34× | ||
| Q3 24 | — | 1.07× | ||
| Q2 24 | — | 1.02× | ||
| Q1 24 | — | 1.25× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ALNY
| TTR | $858.3M | 78% |
| Rare | $136.4M | 12% |
| GIVLAARI | $56.3M | 5% |
| Collaborative Arrangement | $40.9M | 4% |
| ONPATTRO | $12.0M | 1% |
FN
| Optical Communications | $832.6M | 73% |
| Non Optical Communications | $300.3M | 27% |
